Roles of chymase in stenosis occurring after polytetrafluoroethylene graft implantations

Life Sciences

Volumn 81, Issue 16, 2007, Pages 1291-1300

  Jin, Denan ^a   Ueda, Haruhiko ^a   Takai, Shinji ^a   Muramatsu, Michiko ^a   Furubayashi, Keiichi ^a   Ibaraki, Toshihiko ^a   Kishi, Kanta ^a   Katsuoka, Yoji ^a   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiotensin II; Chymase inhibitor; Dog; Polytetrafluoroethylene graft; Stenosis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CHYMASE; CHYMASE INHIBITOR; N [1 BENZYL 2,3 DIOXO 6 (2 PYRIDYLOXY)HEXYL] 2 (5 FORMYLAMINO 1,6 DIHYDRO 6 OXO 2 PHENYL 1 PYRIMIDINYL)ACETAMIDE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOG; FIBROBLAST; GRAFT OCCLUSION; MALE; MAST CELL; MYOFIBROBLAST; NONHUMAN; POLITEF IMPLANT; PROTEIN EXPRESSION;

ACETAMIDES; ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; CELL PROLIFERATION; CHYMASES; CONSTRICTION, PATHOLOGIC; DOGS; ENZYME INHIBITORS; FEMORAL ARTERY; FEMORAL VEIN; MALE; POLYTETRAFLUOROETHYLENE; PYRIMIDINES; TUNICA INTIMA;

CANIS FAMILIARIS;

EID: 35148855037     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.09.004     Document Type: Article

References (28)

1. Border W.A., and Noble N.A. Transforming growth factor β in tissue fibrosis. The New England Journal of Medicine 331 19 (1994) 1286-1292
2. Chen C., Ofenloch J.C., Yianni Y.P., Hanson S.R., and Lumsden A.B. Phosphorylcholine coating of ePTFE reduces platelet deposition and neointimal hyperplasia in arteriovenous grafts. Journal of Surgical Research 77 2 (1998) 119-125
3. Daemen M.J., Lombardi D.M., Bosman F.T., and Schwartz S.M. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circulation Research 68 2 (1991) 450-456
4. Englesbe M.J., Hawkins S.M., Hsieh P.C., Daum G., Kenagy R.D., and Clowes A.W. Concomitant blockade of platelet-derived growth factor receptors alpha and beta induces intimal atrophy in baboon PTFE grafts. Journal of Vascular Surgery 39 2 (2004) 440-446
5. Gibbons G.H., and Dzau V.J. The emerging concept of vascular remodeling. The New England Journal of Medicine 330 20 (1994) 1431-1438
6. Gradzki R., Dhingra R.K., Port F.K., Roys E., Weitzel W.F., and Messana J.M. Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts. American Journal of Kidney Diseases 38 6 (2001) 1240-1244
7. Jin D., Ueda H., Takai S., Okamoto Y., Muramatsu M., Sakaguchi M., Shibahara N., Katsuoka Y., and Miyazaki M. Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs. Journal of the American Society of Nephrology 16 4 (2005) 1024-1034
8. Khan R., Agrotis A., and Bobik A. Understanding the role of transforming growth factor-β1 in intiaml thickening after vascular injury. Cardiovascular Research 74 2 (2007) 223-234
9. Lindstedt K.A., Wang Y., Shiota N., Saarinen J., Hyytiainen M., Kokkonen J.O., Keski-Oja J., and Kovanen P.T. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. The FASEB Journal 15 8 (2001) 1377-1388
10. Liu S.Q. Focal expression of angiotensin II type 1 receptor and smooth muscle cell proliferation in the neointima of experimental vein grafts: relation to eddy blood flow. Arteriosclerosis, Thrombosis, and Vascular Biology 19 11 (1999) 2630-2639
11. Nishimoto M., Takai S., Kim S., Jin D., Yuda A., Sakaguchi M., Yamada M., Sawada Y., Kondo K., Asada K., Iwao H., Sasaki S., and Miyazaki M. Significance of chymase-dependent angiotensin II-forming pathway in the development of vascular proliferation. Circulation 104 11 (2001) 1274-1279
12. Paulin D., and Li Z. Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. Experimental Cell Research 301 1 (2004) 1-7
13. Reilly C.F., Tewksbury D.A., Schechter N.M., and Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. The Journal of Biological Chemistry 257 15 (1982) 8619-8622
14. Schwab S.J. Vascular access for hemodialysis. Kidney International 55 5 (1999) 2078-2090
15. Schwartz S.M., deBlois D., and O'Brien E.R.M. The intima. Soil for atherosclerosis and restenosis. Circulation Research 77 3 (1995) 445-465
16. Shiota N., Okunishi H., Takai S., Mikoshiba I., Sakonjo H., Shibata N., and Miyazaki M. Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery. Circulation 99 8 (1999) 1084-1890
17. Swedberg S.H., Brown B.G., Sigley R., Wight T.N., Gordon D., and Nicholls S.C. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 80 6 (1989) 1726-1736
18. Takai S., Jin D., Sakaguchi M., and Miyazaki M. Chymase-dependent angiotensin II formation in human vascular tissue. Circulation 100 6 (1999) 654-658
19. Takai S., Yuda A., Jin D., Nishimoto M., Sakagichi M., Sasaki S., and Miyazaki M. Inhibition of chymase reduces vascular proliferation in dog grafted veins. FEBS Letters 467 2-3 (2000) 141-144
20. Takai S., Jin D., Nishimoto M., Yuda A., Sakaguchi M., Kamoshita K., Ishida K., Sukenaga Y., Sasaki S., and Miyazaki M. Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein. Life Sciences 69 15 (2001) 1725-1732
21. Takai S., Jin D., Sakaguchi M., Katayama S., Muramatsu M., Sakaguchi M., Matsumura E., Kim S., and Miyazaki M. A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters. Journal of Pharmacology and Experimental Therapeutics 305 1 (2003) 17-23
22. Takai S., Sakonjo H., Fukuda K., Jin D., Sakaguchi M., Kamoshita K., Ishida K., Sukenaga Y., and Miyazaki M. A novel chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[[,4-dioxo-1-phenyl-7-(2-pyridyloxy)]2-heptyl]acetamide (NK3201), suppressed intimal hyperplasia after balloon injury. Journal of Pharmacology and Experimental Therapeutics 304 2 (2003) 841-844
23. Tomasek J.J., McRae J., Owens G.K., and Haaksma C.J. Regulation of alpha-smooth muscle actin expression in granulation tissue myofibroblasts is dependent on the intronic CArG element and the transforming growth factor-beta1 control element. American Journal of Pathology 166 5 (2005) 1343-1351
24. Um J.W., Kim J.M., Min B.W., Kim Y.S., Son G.S., Lee J.B., Jung S.I., Kim S.J., Choi S.Y., Koo B.H., Ishibashi N., Shirouzu K., and Whang C.W. Transforming growth factor-beta1 expression and the role of angiotensin-converting enzyme inhibitor on perianastomotic intimal hyperplasia in polytetrafluoroethylene graft implanted in rabbit carotid artery. Kurume Medical Journal 51 3-4 (2004) 235-243
25. van der Loop F.T., Schaart G., Timmer E.D., Ramaekers F.C., and van Eys G.J. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. The Journal of Biological Chemistry 134 2 (1996) 401-411
26. Wang N., and Stamenovic D. Mechanics of vimentin intermediate filaments. Journal of Muscle Research and Cell Motility 23 5-6 (2002) 535-540
27. Wolf Y.G., Rasmussen L.M., and Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. The Journal of Clinical Investigation 93 3 (1994) 1172-1178
28. Yang X., Zhu M.J., Sreejayan N., Ren J., and Du M. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway. Molecules and Cells 20 2 (2005) 263-270